AV-1959R

· Nuravax, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AV-1959R, covering 2026-02-24 to 2026-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Clinical Study of AV-1959R: Abeta-targeting Anti-Alzheimer's Vaccine [Phase 1]